PeptideLabs Atlas
Peptides. Active compounds. Research focus.
A concise guide to peptides, GLP-1 actives, clinical candidates, community terms, blends and related substances.
- 1Enter a name or alias
- 2Optionally choose a topic
- 3Open the profile, status and primary source
Semaglutide
Peptide
GLP-1 receptor agonist
Effect / research focus
Supports glucose-dependent insulin response and influences appetite and gastric emptying.
Tirzepatide
Peptide
GIP and GLP-1 receptor agonist
Effect / research focus
Activates GIP and GLP-1 receptors and influences glucose regulation, appetite and food intake.
Liraglutide
Peptide
GLP-1 receptor agonist
Effect / research focus
Enhances glucose-dependent insulin signalling and influences satiety and glucagon release.
Dulaglutide
Peptide
Long-acting GLP-1 receptor agonist
Effect / research focus
Promotes glucose-dependent insulin release and reduces the glucagon response when glucose is elevated.
Exenatide
Peptide
GLP-1 receptor agonist
Effect / research focus
Mimics GLP-1 signalling and influences insulin, glucagon, satiety and gastric emptying.
Lixisenatide
Peptide
GLP-1 receptor agonist
Effect / research focus
Influences post-meal glucose mainly through insulin, glucagon and gastric-emptying signals.
Retatrutide
Peptide
GIP, GLP-1 and glucagon receptor agonist
Effect / research focus
Is being studied clinically for body weight, metabolism, and cardiovascular and kidney outcomes.
Cagrilintide
Peptide
Long-acting amylin analogue
Effect / research focus
Is studied alone and with semaglutide for satiety, body weight and glucose control.
Survodutide
Peptide
Glucagon and GLP-1 receptor agonist
Effect / research focus
Is being studied in phase 3 for body weight and metabolic liver disease.
Pemvidutide
Peptide
Glucagon and GLP-1 receptor agonist
Effect / research focus
Research examines effects on body weight, liver fat and metabolic markers.
Cotadutide
Peptide
Glucagon and GLP-1 receptor agonist
Effect / research focus
Has been studied clinically for glucose control, body weight, and liver and kidney markers.
Tesamorelin
Peptide
Growth hormone-releasing factor analogue
Effect / research focus
Stimulates endogenous growth-hormone release; approval is limited to a narrowly defined indication.
CJC-1295 with DAC
Peptide
Long-acting growth hormone-releasing hormone analogue
Effect / research focus
Research aims to prolong growth-hormone and IGF-1 signalling; clinical safety is not established.
Ipamorelin
Peptide
Ghrelin receptor agonist and GH secretagogue
Effect / research focus
Is researched for its effect on growth-hormone pulses; benefit and safety are unconfirmed.
AOD-9604
Peptide
Synthetic fragment of human growth hormone
Effect / research focus
Has been researched for fat metabolism and body weight; robust efficacy and safety data are lacking.
GHRP-2
Peptide
Ghrelin receptor agonist and GH secretagogue
Effect / research focus
Stimulates growth-hormone release in research models and may affect other endocrine signals.
GHRP-6
Peptide
Ghrelin receptor agonist and GH secretagogue
Effect / research focus
Is studied for growth-hormone release and appetite-related ghrelin signalling.
Hexarelin
Peptide
Ghrelin receptor agonist and GH secretagogue
Effect / research focus
Is researched for growth-hormone release and possible cardiometabolic signalling.
BPC-157
Peptide
Synthetic 15-amino-acid gastric peptide fragment
Effect / research focus
Studied preclinically for gastrointestinal tissue and wound repair; clinical benefit and safety are unproven.
TB-500
Peptide
Synthetic thymosin beta-4-related fragment
Effect / research focus
Is discussed experimentally for cell migration and wound repair; human efficacy is unproven.
KPV
Peptide
Alpha-MSH-derived tripeptide
Effect / research focus
Is studied preclinically in relation to inflammation, skin and wound repair.
Thymosin beta-4
Peptide
Endogenous actin-binding peptide
Effect / research focus
Regulates cell migration and tissue processes; therapeutic applications remain largely experimental.
MOTS-c
Peptide
Mitochondrial-derived 16-amino-acid peptide
Effect / research focus
Is studied for cellular energy metabolism, insulin sensitivity, obesity and bone biology.
Elamipretide
Peptide
Mitochondrial cardiolipin-binding tetrapeptide
Effect / research focus
Binds mitochondrial cardiolipin; accelerated U.S. approval covers a narrowly defined rare disease.
Semax
Peptide
Synthetic ACTH-derived peptide
Effect / research focus
Is studied experimentally for neuronal protection and plasticity signalling; it lacks FDA/EMA approval.
Selank
Peptide
Synthetic tuftsin-derived heptapeptide
Effect / research focus
Is researched for anxiety, stress and cognitive signalling; FDA/EMA approval and robust evidence are lacking.
Epitalon
Peptide
Synthetic tetrapeptide
Effect / research focus
Is studied in ageing, sleep and cellular models; clinical benefit is unconfirmed.
DSIP
Peptide
Synthetic nonapeptide
Effect / research focus
Is studied in relation to sleep and stress regulation; evidence and safety data are insufficient.
LL-37
Peptide
Endogenous antimicrobial host-defence peptide
Effect / research focus
Part of innate immunity; antimicrobial, inflammatory and wound-repair signalling are under study.
Afamelanotide
Peptide
Melanocortin-1 receptor agonist
Effect / research focus
Promotes eumelanin production; approval is limited to a rare photosensitivity disorder.
Bremelanotide
Peptide
Melanocortin receptor agonist
Effect / research focus
Influences central melanocortin signalling; approval covers only a specific prescription use.
Melanotan II
Peptide
Non-selective melanocortin receptor agonist
Effect / research focus
Influences pigmentation and other melanocortin signals; safety and purity of unapproved products are uncertain.
HGH / Somatropin
Protein / hormone
Recombinant human growth hormone acting at the growth-hormone receptor
Effect / research focus
Replaces growth hormone in diagnosed deficiency; approved products are prescription-only and limited to defined indications.
5-Amino-1MQ
Small molecule
Experimental small-molecule inhibitor of nicotinamide N-methyltransferase
Effect / research focus
Not a peptide. Studied preclinically in fat-cell and energy metabolism; robust human efficacy and safety data are lacking.
ADAMAX
Peptide
Non-standardised name used in online peptide catalogues
Effect / research focus
The name is not scientifically or regulatorily standardised. Composition and claimed effects may differ by vendor.
AHK-Cu
Peptide
Copper-binding tripeptide studied in skin and hair models
Effect / research focus
Discussed mainly in cosmetic skin and hair models; medicinal benefit and safety are unconfirmed.
GHK-Cu
Peptide
Naturally occurring copper-binding tripeptide
Effect / research focus
Studied in skin-matrix, collagen-signalling and wound models; cosmetic discussion does not establish an approved medical effect.
Vitamin B12
Vitamin
Essential vitamin involved in blood formation, DNA synthesis and nerve function
Effect / research focus
Not a peptide. An essential vitamin whose medical benefit depends on form, diagnosis and actual deficiency.
BPC-157 + TB-500
Non-standardised blend
Non-standardised blend name combining two unapproved research peptides
Effect / research focus
Linked in communities to tissue and recovery claims. The blend lacks approval, standardisation and confirmed human efficacy.
Tesamorelin + Ipamorelin
Non-standardised blend
Non-standardised combination of two growth-hormone signalling compounds
Effect / research focus
Discussed online as a growth-hormone signalling combination. The blend is not approved and lacks robust safety data.
Selank + Semax
Non-standardised blend
Non-standardised blend of two experimental neuropeptides
Effect / research focus
Linked in communities to stress and cognition claims; clinical benefit and safety of the blend are unproven.
BPC-157 + GHK-Cu + KPV
Non-standardised blend
Vendor-defined blend of three unapproved research peptides
Effect / research focus
Marketed online around skin, inflammation and repair themes. Composition, safety and effects are neither standardised nor confirmed.
GLOW blend
Non-standardised blend
Community and vendor shorthand, commonly used for a variable multi-peptide blend
Effect / research focus
Not a standardised medicinal name. Commonly marketed around skin and repair; actual composition may vary.
KLOW blend
Non-standardised blend
Community and vendor shorthand for a non-standardised multi-peptide blend
Effect / research focus
Not a standardised medicinal name. Linked to skin, inflammation and repair themes; composition and effects are unconfirmed.
CJC-1295 no DAC
Peptide
Shorter-acting GHRH analogue without the drug-affinity complex
Effect / research focus
Distinguished online from the DAC version and discussed for growth-hormone signalling; approval and confirmed safety are lacking.
CJC-1295 no DAC + Ipamorelin
Non-standardised blend
Non-standardised combination targeting GHRH and ghrelin-receptor signalling
Effect / research focus
Combined online around growth-hormone signalling. The blend is unapproved, with unconfirmed safety and benefit.
MGF
Peptide
Locally expressed IGF-1 splice variant associated with mechanical stress
Effect / research focus
Studied in muscle and repair research; MGF products sold online are not approved medicines.
PEG-MGF
Peptide
PEGylated experimental MGF-related compound
Effect / research focus
Designed to alter persistence of an MGF-related molecule; reliable clinical data and approval are lacking.
450 (unidentified)
Not clearly identified
Insufficient name information for a reliable scientific identification
Effect / research focus
The label “450” is insufficient for reliable identification. No effect or substance class is invented.
Glutathione
Peptide
Endogenous tripeptide central to cellular redox chemistry
Effect / research focus
An endogenous tripeptide and antioxidant. Product claims depend heavily on formulation and route; compounded sterile products add risks.
IGF-1 LR3
Protein / hormone
Long-acting experimental analogue of insulin-like growth factor 1
Effect / research focus
Linked to growth, metabolic and muscle themes; as an unapproved analogue it lacks confirmed safety and benefit.
Kisspeptin-10
Peptide
KISS1 receptor agonist influencing the reproductive hormone axis
Effect / research focus
Studied clinically for GnRH, LH and reproductive signalling; not a generally approved medicine.
Lipo-C
Non-standardised blend
Non-standardised vendor name for a variable lipotropic mixture
Effect / research focus
Not a peptide and not a uniform formula. Ingredients may vary by vendor, so claims cannot be generalised.
Lipo-B
Non-standardised blend
Non-standardised vendor name for a vitamin-based lipotropic mixture
Effect / research focus
Not a peptide or a standardised medicinal name. Composition and claimed effects differ by vendor.
L-Carnitine
Amino-acid derivative
Amino-acid derivative transporting long-chain fatty acids into mitochondria
Effect / research focus
Not a peptide. Approved medicines exist for specific diagnosed deficiencies; general fitness claims are separate.
NAD+
Cofactor
Endogenous redox cofactor involved in cellular energy metabolism
Effect / research focus
Not a peptide. An endogenous cofactor; wellness and anti-ageing claims do not equal approved efficacy.
SNAP-8
Peptide
Synthetic cosmetic octapeptide marketed around expression-line appearance
Effect / research focus
Primarily a cosmetic ingredient. Marketing around wrinkles or expression lines is not an approved medicinal effect.
Oxytocin
Peptide
Endogenous peptide hormone acting at the oxytocin receptor
Effect / research focus
Regulates labour and milk-ejection signalling, among other functions. Approved uses are prescription-only and medically supervised.
ARA-290 / Cibinetide
Peptide
Non-haematopoietic erythropoietin-derived tissue-protective peptide
Effect / research focus
Studied clinically for inflammatory, nerve and metabolic outcomes; it lacks general medicinal approval.
Sermorelin
Peptide
Synthetic fragment of growth hormone-releasing hormone
Effect / research focus
Stimulates GHRH-receptor signalling. There is currently no generally marketed FDA/EMA-approved sermorelin medicine.
Thymosin Alpha-1
Peptide
Synthetic version of an endogenous immune-modulating peptide
Effect / research focus
Studied for immune modulation and approved for specific uses in some countries, but not generally by FDA or EMA.
Thymalin
Non-standardised blend
Non-standardised thymus-derived peptide preparation name
Effect / research focus
Linked to immune and ageing themes. Composition, evidence and regulatory status are not internationally standardised.
VIP
Peptide
Endogenous neuropeptide acting at VPAC receptors
Effect / research focus
Influences vascular, intestinal, pulmonary and neural signalling. Therapeutic uses and analogues remain under clinical study.
Bacteriostatic Water
Support solution
Sterile diluent product; not a peptide or active research compound
Effect / research focus
Not a peptide or active compound. Labelling, sterility and intended use vary; no mixing instructions are provided here.
Status checked: August 2026